The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Are Rare Variants Responsible for Susceptibility to Complex Diseases?
Open accessAbstract
Little is known about the nature of genetic variation underlying complex diseases in humans. One popular view proposes that mapping efforts should focus on identification of susceptibility mutations that are relatively old and at high frequency. It is generally assumed-at least for modeling purposes-that selection against complex disease mutations is so weak that it can be ignored. In this article, I propose an explicit model for the evolution of complex disease loci, incorporating mutation, random genetic drift, and the possibility of purifying selection against susceptibility mutations. I show that, for the most plausible range of mutation rates, neutral susceptibility alleles are unlikely to be at intermediate frequencies and contribute little to the overall genetic variance for the disease. Instead, it seems likely that the bulk of genetic variance underlying diseases is due to loci where susceptibility mutations are mildly deleterious and where there is a high overall mutation rate to the susceptible class. At such loci, the total frequency of susceptibility mutations may be quite high, but there is likely to be extensive allelic heterogeneity at many of these loci. I discuss some practical implications of these results for gene mapping efforts.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Rare variants also contribute to disease risk14-17.”
From Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease (2017) · cites this paper as [15]
In the citing paper
“These findings are consistent with the high levels of expression of both PLCG2 and ABI3 in peripheral monocytes, spleen, and whole blood reported by the ROADmap project and in microglia as reported by Zhang et al15.”
From Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease (2017) · cites this paper as [15]
In the citing paper
“This suggests that these elevations are likely a consequence of changes in cell types that occur with AD, most likely microgliosis given that TREM2, PLCG2 and ABI3 are microglia-enriched genes15 (Supplementary Table 19, Supplementary Figure 12).”
From Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease (2017) · cites this paper as [15]
In the citing paper
“Arguably a fundamental difficulty is that most of the mutations with large effects tend to be under strong negative selection, existing at very low frequencies in the population [22].”
From Integrated Model of De Novo and Inherited Genetic Variants Yields Greater Power to Identify Risk Genes (2013) · cites this paper as [22]
In the citing paper
“There are many reasons to believe that multiple rare variants, both within the same gene and across different genes, collectively influence the expression and prevalence of traits and diseases in the population at large.”
From Statistical analysis strategies for association studies involving rare variants (2010) · cites this paper as [15]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Markov Chain Monte Carlo in Practice
(1995) · Chapman & Hall/CRC eBooks · doi:10.1201/b14835 · Cited by 7,757
The Future of Genetic Studies of Complex Human Diseases
Risch, N., & Merikangas, K. (1996) · Science · doi:10.1126/science.273.5281.1516 · Cited by 5,355 · cited 6×
“Under the " common disease, common variant " hypothesis, it may be possible to create a catalogue of common SNPs and to use association mapping to identify disease-susceptibility mutations from that list (Risch and Merikangas 1996; Cargill et al. 1999; Halushka et al. 1999).”
BackgroundResultInfluentialSpielman, R. S., McGinnis, R. E., & Ewens, W. J. (1993) · PubMed · Cited by 3,651
Searching for genetic determinants in the new millennium
Risch, N. J. (2000) · Nature · doi:10.1038/35015718 · Cited by 1,839 · cited 1×
“Mapping the genes that contribute to complex diseases—such as diabetes, schizophrenia, and hypertension—will be a major challenge of the postgenome era (Risch 2000).”
BackgroundGene genealogies and the coalescent process.
Hudson, R. R. (1990) · Medical Entomology and Zoology · Cited by 1,838
Mathematical Population Genetics
Baake, E., Ewens, W. J., & Wakolbinger, A. (2006) · Oberwolfach Reports · doi:10.4171/owr/2005/40 · Cited by 1,624
Characterization of single-nucleotide polymorphisms in coding regions of human genes
Cargill, M., Altshuler, D., Ireland, J., Sklar, P., Ardlie, K., Patil, N., Lane, C. R., Lim, E. P., Kalyanaraman, N., Nemesh, J., et al. (1999) · Nature Genetics · doi:10.1038/10290 · Cited by 1,547 · cited 1×
“One popular hypothesis proposes that the genetic factors underlying common diseases will be alleles that are themselves quite common in the population at large (Lander 1996; Chakravarti 1999).”
BackgroundOXFORD SURVEYS IN EVOLUTIONARY BIOLOGY
Allendorf, F. W. (1989) · Evolution · doi:10.1111/j.1558-5646.1989.tb02584.x · Cited by 1,449
Prospects for whole-genome linkage disequilibrium mapping of common disease genes
Kruglyak, L. (1999) · Nature Genetics · doi:10.1038/9642 · Cited by 1,416 · cited 5×
“Assumptions about the likely frequency spectrum of disease mutations are also critical in modeling linkage disequilibrium (Kruglyak 1999; Long and Langley 1999; Zöllner and von Haeseler 2000).”
BackgroundInfluentialLinkage strategies for genetically complex traits. I. Multilocus models.
RISCH, N. J. (1990) · PubMed · Cited by 1,309
Cited by
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089
“Under this model, the considerable levels of heritability could reflect aggregates of very many, very rare variants (each potentially of moderate effect but accounting for virtually none of the variation at the population level), which we refer to as the “multiple rare variant” (MRV) hypothesis.(13) Standard associati…”
BackgroundFinding the missing heritability of complex diseases
Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., McCarthy, M. I., Ramos, E. M., Cardon, L. R., Chakravarti, A., et al. (2009) · Nature · doi:10.1038/nature08494 · Cited by 8,336
Common SNPs explain a large proportion of the heritability for human height
Yang, J., Benyamin, B., McEvoy, B. P., Gordon, S., Henders, A. K., Nyholt, D. R., Madden, P. A., Heath, A. C., Martin, N. G., Montgomery, G. W., et al. (2010) · Nature Genetics · doi:10.1038/ng.608 · Cited by 4,446
A genome-wide association study identifies novel risk loci for type 2 diabetes
Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007) · Nature · doi:10.1038/nature05616 · Cited by 2,993
Genome-wide association studies for common diseases and complex traits
Hirschhorn, J. N., & Daly, M. J. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1521 · Cited by 2,863
“Variants that cause monogenic disorders are often rare (probably because negative selection reduces the frequencies of variants that cause diseases characterized by early-onset morbidity and mortalit”
Background
Metadata
- Authors
- Pritchard, J. K.
- Affiliations
- University of Oxford (GB)
- Corresponding author
- Pritchard, Jonathan K.
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2001-07
- Volume
- 69
- Issue
- 1
- Pages
- 124-137
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC1226027
- OpenAlex
- W2129559300
- Cited by
- 1,197
- References
- 42
- Citations by year
- 2026: 9 · 2025: 11 · 2024: 15 · 2023: 8 · 2022: 17 · 2021: 18 · 2020: 11 · 2019: 39 · 2018: 41 · 2017: 40 · 2016: 50 · 2015: 58 · 2014: 68 · 2013: 69 · 2012: 78
- FWCI
- 30.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 4401 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Burroughs Wellcome Fund
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- complex diseases, rare variants, purifying selection, genetic drift, mutation rate, genetic variance, allelic heterogeneity, gene mapping, deleterious mutations
- MeSH terms
- Alleles, Chromosome Mapping, Computer Simulation, Female, Gene Frequency, Humans, Genetic Linkage, Male, Models, Genetic, Mutation, Pedigree, Phenotype, Polymorphism, Genetic, Probability, Selection, Genetic, Software, Genetic Variation, Mutagenesis, Genetic Heterogeneity, Genetic Predisposition to Disease, Genetic Diseases, Inborn
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Are Rare Variants Responsible for Susceptibility to Complex Diseases? https://app.cochat.ai/papers/10.1086/321272
- The paper
- Pritchard, J. K. (2001). Are Rare Variants Responsible for Susceptibility to Complex Diseases? The American Journal of Human Genetics. https://doi.org/10.1086/321272
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.